{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:21:25Z","timestamp":1787023285496,"version":"build-2736575974"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":1601,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adipose tissue is an endocrine organ that could play a role in tumor progression via its secreted adipokines. The role of adipose-derived fatty acid-binding protein (FABP) 4 and FABP5 in breast cancer is presently under study, but their circulating levels in this pathology are poorly known. We analyzed the blood concentrations of FABP4 and FABP5 in breast cancer patients to determine whether there is an association between them and breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>We studied 294 women in the oncology department with a family history of breast cancer; 198 of the women had breast cancer, and 96 were healthy controls. The levels of FABP4, FABP5, lipid profile, standard biochemical parameter, and high-sensitivity C-reactive protein (hsCRP) were determined. We analyzed the association of FABP4 and FABP5 with breast cancer, while adjusting for demographic, anthropometric, and biochemical parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Breast cancer patients had a 24.8% (p\u2009&amp;lt;\u2009.0001) and 11.4% (p\u2009&amp;lt;\u2009.05) higher blood concentration of FABP4 and FABP5, respectively. Fatty acid-binding protein 4 was positively associated with age, body mass index (BMI), FABP5, very-low-density lipoprotein cholesterol (VLDLc), non-high-density lipoprote in cholesterol (non-HDLc), Apolipoprotein B 100 (ApoB100), triglycerides, glycerol, glucose, and hsCRP (p\u2009&amp;lt;\u2009.05), and was negatively associated with HDLc (p\u2009&amp;lt;\u2009.005) in breast cancer patients. Fatty acid-binding protein 5 was positively associated with BMI, FABP4, VLDLc, triglycerides, glycerol, and hsCRP (p\u2009&amp;lt;\u2009.05), and was negatively associated with HDLc and Apolipoprotein AI (ApoAI) (p\u2009&amp;lt;\u2009.05) in breast cancer patients. Using a logistic regression analysis and adjusting for age, BMI, hsCRP, non-HDLc, and triglycerides, FABP4 was independently associated with breast cancer (odds ratio [OR]: 1.091 [95% CI: 1.037\u20131.149]). Moreover, total cholesterol, VLDLc, non-HDLc, ApoB100, triglycerides, and hsCRP were significantly increased in breast cancer patients (p\u2009&amp;lt;\u2009.005). In contrast, the non-esterified fatty acids concentrations were significantly decreased in breast cancer patients (p\u2009&amp;lt;\u2009.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Circulating FABP4 and FABP5 levels were increased in breast cancer patients compared with controls. The positive association of FABP4 with breast cancer was maintained after adjusting for important covariates, while the association with FABP5 was lost. Our data reinforce the role of adipose tissue and their adipokines in breast cancer. Despite these data, further studies must be performed to better explain the prognosis or diagnostic value of these blood parameters and their possible role in breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1634\/theoncologist.2016-0483","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T21:20:17Z","timestamp":1499894417000},"page":"1309-1315","source":"Crossref","is-referenced-by-count":40,"title":["Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients"],"prefix":"10.1093","volume":"22","author":[{"given":"Sandra","family":"Guaita-Esteruelas","sequence":"first","affiliation":[{"name":"Institut d'Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), Centre d'R+D+I en Nutrici\u00f3 i Salut, Avda. de la Universitat, Reus, Spain"},{"name":"Research Unit on Lipids and Atherosclerosis, Universitat Rovira i Virgili, Sant Lloren\u00e7, Reus, Spain"},{"name":"Institut d'Oncologia de la Catalunya Sud (IOCS), Hospital Universitari Sant Joan de Reus, IISPV, Universitat Rovira i Virgili, Av. del Dr. Josep Laporte, Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Saavedra-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Research Unit on Lipids and Atherosclerosis, Universitat Rovira i Virgili, Sant Lloren\u00e7, Reus, Spain"},{"name":"Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine (ICTEM), Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Bosquet","sequence":"additional","affiliation":[{"name":"Institut d'Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), Centre d'R+D+I en Nutrici\u00f3 i Salut, Avda. de la Universitat, Reus, Spain"},{"name":"Research Unit on Lipids and Atherosclerosis, Universitat Rovira i Virgili, Sant Lloren\u00e7, Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Borr\u00e0s","sequence":"additional","affiliation":[{"name":"Institut d'Oncologia de la Catalunya Sud (IOCS), Hospital Universitari Sant Joan de Reus, IISPV, Universitat Rovira i Virgili, Av. del Dr. Josep Laporte, Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa","family":"Girona","sequence":"additional","affiliation":[{"name":"Research Unit on Lipids and Atherosclerosis, Universitat Rovira i Virgili, Sant Lloren\u00e7, Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kepa","family":"Amiliano","sequence":"additional","affiliation":[{"name":"Institut d'Oncologia de la Catalunya Sud (IOCS), Hospital Universitari Sant Joan de Reus, IISPV, Universitat Rovira i Virgili, Av. del Dr. Josep Laporte, Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rodr\u00edguez-Balada","sequence":"additional","affiliation":[{"name":"Institut d'Oncologia de la Catalunya Sud (IOCS), Hospital Universitari Sant Joan de Reus, IISPV, Universitat Rovira i Virgili, Av. del Dr. Josep Laporte, Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Heras","sequence":"additional","affiliation":[{"name":"Research Unit on Lipids and Atherosclerosis, Universitat Rovira i Virgili, Sant Lloren\u00e7, Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Masana","sequence":"additional","affiliation":[{"name":"Research Unit on Lipids and Atherosclerosis, Universitat Rovira i Virgili, Sant Lloren\u00e7, Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Gum\u00e0","sequence":"additional","affiliation":[{"name":"Institut d'Oncologia de la Catalunya Sud (IOCS), Hospital Universitari Sant Joan de Reus, IISPV, Universitat Rovira i Virgili, Av. del Dr. Josep Laporte, Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,12]]},"reference":[{"key":"2021122508320050700_R1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"2021122508320050700_R2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/hmbci-2014-0043","article-title":"Body fatness, related biomarkers and cancer risk: An epidemiological perspective","volume":"22","author":"Nimptsch","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"key":"2021122508320050700_R3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/obr.12281","article-title":"The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: Potential effects of exercise","volume":"16","author":"Schmidt","year":"2015","journal-title":"Obes Rev"},{"key":"2021122508320050700_R4","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/bjc.2011.481","article-title":"8. Cancers attributable to overweight and obesity in the UK in 2010","volume":"105","author":"Parkin","year":"2011","journal-title":"Br J Cancer"},{"key":"2021122508320050700_R5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1758-5996-3-12","article-title":"Visceral adiposity, insulin resistance and cancer risk","volume":"3","author":"Donohoe","year":"2011","journal-title":"Diabetol Metab Syndr"},{"key":"2021122508320050700_R6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.33549\/physiolres.930848","article-title":"Adipocytokines and cancer","volume":"55","author":"Housa","year":"2006","journal-title":"Physiol Res"},{"key":"2021122508320050700_R7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1677\/ERC-06-0068","article-title":"Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression","volume":"14","author":"Vona-Davis","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"2021122508320050700_R8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1515\/hmbci-2014-0037","article-title":"Adipose tissue, obesity and adipokines: Role in cancer promotion","volume":"21","author":"Booth","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"key":"2021122508320050700_R9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1479-7364-5-3-170","article-title":"The human fatty acid-binding protein family: Evolutionary divergences and functions","volume":"5","author":"Smathers","year":"2011","journal-title":"Hum Genomics"},{"key":"2021122508320050700_R10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"2021122508320050700_R11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacl.2015.12.012","article-title":"Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders","volume":"10","author":"Ibarretxe","year":"2016","journal-title":"J Clin Lipidol"},{"key":"2021122508320050700_R12","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1194\/jlr.M800102-JLR200","article-title":"Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes","volume":"49","author":"Cabr\u00e9","year":"2008","journal-title":"J Lipid Res"},{"key":"2021122508320050700_R13","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1016\/j.atherosclerosis.2007.04.045","article-title":"Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients","volume":"195","author":"Cabr\u00e9","year":"2007","journal-title":"Atherosclerosis"},{"key":"2021122508320050700_R14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1373\/clinchem.2005.062463","article-title":"Adipocyte fatty acid\u2013binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome","volume":"52","author":"Xu","year":"2006","journal-title":"Clin Chem"},{"key":"2021122508320050700_R15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2337\/diabetes.52.2.300","article-title":"Role of the fatty acid binding protein mal1 in obesity and insulin resistance","volume":"52","author":"Maeda","year":"2003","journal-title":"Diabetes"},{"key":"2021122508320050700_R16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc08-1333","article-title":"Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients","volume":"32","author":"Yeung","year":"2009","journal-title":"Diabetes Care"},{"key":"2021122508320050700_R17","doi-asserted-by":"crossref","first-page":"e81914","DOI":"10.1371\/journal.pone.0081914","article-title":"FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway","volume":"8","author":"Girona","year":"2013","journal-title":"PLoS One"},{"key":"2021122508320050700_R18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mc.22485","article-title":"Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins","volume":"56","author":"Guaita-Esteruelas","year":"2016","journal-title":"Mol Carcinog"},{"key":"2021122508320050700_R19","doi-asserted-by":"crossref","first-page":"838652","DOI":"10.1155\/2015\/838652","article-title":"Docosahexaenoic acid modulates a HER2-associated lipogenic phenotype, induces apoptosis, and increases trastuzumab action in HER2-overexpressing breast carcinoma cells","volume":"2015","author":"Ravacci","year":"2015","journal-title":"Biomed Res Int"},{"key":"2021122508320050700_R20","doi-asserted-by":"crossref","first-page":"e0119473","DOI":"10.1371\/journal.pone.0119473","article-title":"Differential expression of lipid metabolism-related proteins in different breast cancer subtypes","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"2021122508320050700_R21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10549-009-0577-9","article-title":"Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients","volume":"119","author":"Hancke","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"2021122508320050700_R22","doi-asserted-by":"crossref","first-page":"35830","DOI":"10.18632\/oncotarget.5767","article-title":"Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"2021122508320050700_R23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12943-015-0380-7","article-title":"CRABP1 is associated with a poor prognosis in breast cancer: Adding to the complexity of breast cancer cell response to retinoic acid","volume":"14","author":"Liu","year":"2015","journal-title":"Mol Cancer"},{"key":"2021122508320050700_R24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ajpath.2010.11.075","article-title":"Association of FABP5 expression with poor survival in triple-negative breast cancer: Implication for retinoic acid therapy","volume":"178","author":"Liu","year":"2011","journal-title":"Am J Pathol"},{"key":"2021122508320050700_R25","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.18632\/oncotarget.3442","article-title":"Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability","volume":"6","author":"Powell","year":"2015","journal-title":"Oncotarget"},{"key":"2021122508320050700_R26","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1186\/1471-2407-14-724","article-title":"Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells","volume":"14","author":"Thulasiraman","year":"2014","journal-title":"BMC Cancer"},{"key":"2021122508320050700_R27","doi-asserted-by":"crossref","first-page":"19106","DOI":"10.1074\/jbc.M109.099770","article-title":"Fatty acid-binding protein 5 and PPARbeta\/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth","volume":"285","author":"Kannan-Thulasiraman","year":"2010","journal-title":"J Biol Chem"},{"key":"2021122508320050700_R28","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1158\/0008-5472.CAN-13-0384","article-title":"Genetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis","volume":"73","author":"Levi","year":"2013","journal-title":"Cancer Res"},{"key":"2021122508320050700_R29","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1073\/pnas.0709981105","article-title":"Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta\/delta to RAR","volume":"105","author":"Schug","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021122508320050700_R30","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"2021122508320050700_R31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12913-015-1018-6","article-title":"Immunohistochemical expression of HER2 in breast cancer: Socioeconomic impact of inaccurate tests","volume":"15","author":"Vyberg","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"2021122508320050700_R32","doi-asserted-by":"crossref","first-page":"18984","DOI":"10.18632\/oncotarget.7920","article-title":"A single-nucleotide polymorphism in the 3\u2032-UTR region of the adipocyte fatty acid binding protein 4 gene is associated with prognosis of triple-negative breast cancer","volume":"7","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"2021122508320050700_R33","doi-asserted-by":"crossref","first-page":"e0137204","DOI":"10.1371\/journal.pone.0137204","article-title":"Expression of lipid metabolism-related proteins in metastatic breast cancer","volume":"10","author":"Jung","year":"2015","journal-title":"PLoS One"},{"key":"2021122508320050700_R34","first-page":"PC01","article-title":"A comparitive study to evaluate the role of serum lipid levels in aetiology of carcinoma breast","volume":"9","author":"Kumar","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"2021122508320050700_R35","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1194\/jlr.M800668-JLR200","article-title":"Signaling through cholesterol esterification: A new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion","volume":"50","author":"Paillasse","year":"2009","journal-title":"J Lipid Res"},{"key":"2021122508320050700_R36","first-page":"562","article-title":"The role of developing breast cancer in alteration of serum lipid profile","volume":"17","author":"Abdelsalam","year":"2012","journal-title":"J Res Med Sci"},{"key":"2021122508320050700_R37","first-page":"389","article-title":"Dietary fatty acids affect lipid metabolism and estrogen receptor expression in N-methyl-N-nitrosourea-induced rat mammary cancer model","volume":"61","author":"Zhang","year":"2015","journal-title":"Clin Lab"},{"key":"2021122508320050700_R38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4615-2942-2_17","article-title":"High serum HDL-cholesterol in pre- and post-menopausal women with breast cancer in southern Italy","volume":"348","author":"Borrelli","year":"1993","journal-title":"Adv Exp Med Biol"},{"key":"2021122508320050700_R39","doi-asserted-by":"crossref","first-page":"e46456","DOI":"10.1371\/journal.pone.0046456","article-title":"The lipid phenotype of breast cancer cells characterized by raman microspectroscopy: Towards a stratification of malignancy","volume":"7","author":"Nieva","year":"2012","journal-title":"PLoS One"},{"key":"2021122508320050700_R40","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/ijc.30194","article-title":"Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population","volume":"139","author":"Allin","year":"2016","journal-title":"Int J Cancer"},{"key":"2021122508320050700_R41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10549-016-3802-3","article-title":"Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: A cross-sectional study","volume":"157","author":"Agresti","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"2021122508320050700_R42","first-page":"180","article-title":"Concentration study of high sensitive C - reactive protein and some serum trace elements in patients with benign and malignant breast tumor","volume":"9","author":"Abdollahi","year":"2015","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"2021122508320050700_R43","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1194\/jlr.M900066-JLR200","article-title":"FABP4 plasma levels are increased in familial combined hyperlipidemia","volume":"51","author":"Cabr\u00e9","year":"2010","journal-title":"J Lipid Res"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2016-0483","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2016-0483","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/22\/11\/1309\/41913460\/oncolo_22_11_1309.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/22\/11\/1309\/41913460\/oncolo_22_11_1309.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T08:43:23Z","timestamp":1719305003000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/22\/11\/1309\/6444712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,12]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,7,12]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2016-0483","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11,1]]},"published":{"date-parts":[[2017,7,12]]}}}